Literature DB >> 6355082

Rapid, reversible internalization of cell surface insulin receptors. Correlation with insulin-induced down-regulation.

V P Knutson, G V Ronnett, M D Lane.   

Abstract

Chronic treatment of 3T3-C2 fibroblasts with insulin causes the slow (t1/2 = 3-4 h) down-regulation of cellular insulin receptor to a new steady state level by accelerating receptor decay (Knutson, V.P., Ronnett, G.V., and Lane, M.D. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 2822-2826). In the present investigation, the synthesis and turnover of the receptor during the transition to the down-regulated state was examined by the heavy isotope density-shift method. It was observed that within two h after insulin addition, receptor decay increased abruptly for several hours then gradually declined until the "down-regulated" rate was achieved. The abrupt increase in receptor decay induced by insulin was preceded by a more rapid (t1/2 less than or equal to 10 min) translocation of cell surface receptor to an "intracellular" trypsin-resistant compartment. Thus, upon exposure to ligand, insulin receptor rapidly redistributes from the cell surface to an intracellular compartment, without an initial net loss of cellular receptors. The translocation process was rapidly reversed (t1/2 less than or equal to 20 min) upon removal of insulin. With prolonged exposure to insulin, the initial rapid translocation of receptor was followed by a slower inactivation of receptor apparently in the intracellular compartment. Cycloheximide, which lengthens receptor half-life by blocking a step in receptor inactivation, had no effect on receptor internalization. Internalization of insulin receptor and its bound ligand were, however, rapidly (less than 10 min) blocked by phenylarsine oxide. These results support the following sequence of events. Upon exposure to ligand, insulin receptors are translocated from the cell surface to an intracellular site which results in accelerated receptor decay and ultimately to a lower steady state cellular receptor level.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6355082

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Receptor recruitment: a mechanism for interactions between G protein-coupled receptors.

Authors:  U Holtbäck; H Brismar; G F DiBona; M Fu; P Greengard; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Redox modulation of basal and beta-adrenergically stimulated cardiac L-type Ca(2+) channel activity by phenylarsine oxide.

Authors:  Carl Sims; Robert D Harvey
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

Review 3.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

4.  Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.

Authors:  Joseph A Falcone; Therese S Salameh; Xiang Yi; Benjamin J Cordy; William G Mortell; Alexander V Kabanov; William A Banks
Journal:  J Pharmacol Exp Ther       Date:  2014-07-15       Impact factor: 4.030

5.  3T3-L1 adipocytes as a cell culture model of insulin resistance.

Authors:  V P Knutson; Y Balba
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-02       Impact factor: 2.416

6.  Insulin-dependent changes in subcellular distribution of liver insulin receptors in obese Zucker rats.

Authors:  S López; B Desbuquois; M C Postel-Vinay; C Benelli; M Lavau
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

7.  Proteolytic generation of constitutive tyrosine kinase activity of the human insulin receptor.

Authors:  J J Hsuan; J Downward; S Clark; M D Waterfield
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

8.  Involvement of hormone processing in insulin-activated glucose transport by isolated cardiac myocytes.

Authors:  J Eckel; H Reinauer
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

9.  Inhibitors of protein synthesis also inhibit lysosomal proteolysis. Studies using cystinotic fibroblasts.

Authors:  J G Thoene; R Lemons; S Boskovich; K Borysko
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

10.  Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols.

Authors:  Jason Pitt; Michael Thorner; David Brautigan; Joseph Larner; William L Klein
Journal:  FASEB J       Date:  2012-10-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.